Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 16/20 | 0.58 |
| ▸ | NTSR1 | P30989 | 16/20 | 0.58 |
| ▸ | SORT1 | Q99523 | 14/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29467322 | 0.97 | OPRD1 (0.56) | NTSR2NTSR1SORT1 | |
| SCHEMBL29510574 | 0.90 | F2 (0.62) | NTSR2NTSR1AGTR2AGTR1 | |
| SCHEMBL30504141 | 0.88 | NTSR1 (0.57) | NTSR2NTSR1SORT1SLC6A2AGTR2 | |
| SCHEMBL29793680 | 0.87 | F2 (0.64) | NTSR2NTSR1SORT1AGTR2AGTR1 | |
| SCHEMBL30969929 | 0.86 | F2 (0.58) | NTSR2NTSR1SORT1AGTR2AGTR1 | |
| SCHEMBL30198139 | 0.86 | NPY1R (0.55) | NTSR2NTSR1SORT1 | |
| SCHEMBL30176449 | 0.86 | CALCR (0.60) | NTSR2NTSR1SORT1 | |
| SCHEMBL29590984 | 0.85 | NTSR2 (0.49) | NTSR2NTSR1SORT1 | |
| SCHEMBL30637760 | 0.85 | NTSR1 (0.64) | NTSR2NTSR1SORT1SLC6A2AGTR2 | |
| SCHEMBL29860392 | 0.85 | NTSR1 (0.64) | NTSR2NTSR1SORT1SLC6A2AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115919996-A | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2023-04-07 | — | — | CN | claimed |
| US-20230074446-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2023-03-09 | — | — | US | claimed |
| US-20220331393-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2022-10-20 | — | — | US | claimed |
| US-11464825-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-10-11 | — | — | US | claimed |
| US-11273197-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-03-15 | — | — | US | claimed |
| CN-115919996-A | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20230074446-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2023-03-09 | — | — | US | disclosed |
| US-20220331393-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2022-10-20 | — | — | US | disclosed |
| US-11464825-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| CN-107530396-B | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2022-08-26 | — | — | CN | disclosed |
| EP-4014985-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | Allysta Pharmaceuticals, Inc. (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11273197-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-03-15 | — | — | US | disclosed |